1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pakistan Pharmaceuticals and Healthcare Report Q3 2016

Pakistan Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 106 pages

Includes 3 FREE quarterly updates

BMI View: Healthcare expenditure in Pakistan will grow strongly, albeit from a low base. Central to thistrajectory is the rise in household incomes as out-of-pocket health spending remains a dominant source ofhealthcare financing. This is further supported by the higher health expenditure by administrative unitauthorities which have outlined long-term medical strategies. At the sub-national level, the strongestcommercial prospects for pharmaceutical and medical device companies will be in the more economicallydeveloped provinces of Punjab and Sindh.

Headline Expenditure Projections

- Pharmaceuticals: PKR252bn (USD2.5bn) in 2015 to PRK274bn (USD2.6bn) 2016; +8.5%in localcurrency terms and +5.1% in US dollar terms.

- Healthcare: PKR741bn (USD7.2bn) in 2015 to PKR812bn (USD7.7bn) in 2016; +9.6% in localcurrency terms and +6.2% in US dollar terms.

Table Of Contents

Pakistan Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Pakistan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Pakistan 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2012-2020) 16
Table: Government Healt Expenditure Trends, Historical Data And Forecasts (Pakistan 2010-2018) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Pakistan 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Pakistan 2014-2020) 31
Industry Risk/Reward Index 32
Asia Pacific Risk/Reward Index - Q3 2016 32
Pakistan Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Regulatory Developments 43
Intellectual Property Issues 43
Pricing Regime 44
Reimbursement Regime 46
Market Overview 48
Healthcare Sector 49
Table: Healthcare Resources (Pakistan 2010-2015) 51
Table: Healthcare Personnel (Pakistan 2010-2015) 51
Table: Healthcare Activity (Pakistan 2010-2015) 52
Research and Development 52
Clinical Trials 53
Epidemiology 54
Table: Diabetic Patients' Education Level and Compliance Levels 56
Table: Estimated Number Of New Cases Of Cancer In Pakistan 57
Table: Frequency Of Information Provided To Patients As A Percentage Of Total Cases 57
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 59
Generic Drugmakers 60
Table: PPMA As Of 2015 61
Pharmaceutical Distribution 64
Company Profile 66
Abbott Laboratories 66
Efroze Chemical Industries 70
Ferozsons Laboratories 73
Getz Pharma 76
GlaxoSmithKline 79
Hilton Pharma 83
Novartis 85
Pfizer 87
Sanofi-Aventis 90
Searle Pakistan Limited 93
Demographic Forecast 95
Table: Population Headline Indicators (Pakistan 1990-2025) 96
Table: Key Population Ratios (Pakistan 1990-2025) 96
Table: Urban/Rural Population and Life Expectancy (Pakistan 1990-2025) 97
Table: Population By Age Group (Pakistan 1990-2025) 97
Table: Population By Age Group % (Pakistan 1990-2025) 98
Glossary 100
Methodology 102
Pharmaceutical Expenditure Forecast Model 102
Healthcare Expenditure Forecast Model 102
Notes On Methodology 103
Risk/Reward Index Methodology 104
Index Overview 105
Table: Pharmaceutical Risk/Reward Index Indicators 105
Indicator Weightings 106

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.